Trial Profile
A study of lenalidomide dose modification in patients with myelodysplastic syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jan 2016
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma; Myelodysplastic syndromes
- Focus Therapeutic Use
- 21 Jan 2016 New trial record
- 08 Dec 2015 Results of retrospective study presented at the 57th Annual Meeting and Exposition of the American Society of Hematology